The Emergence of Somatostatin Antagonist–Based Theranostics: Paving the Road Toward Another Success?
Alessio Impériale, Abhishek Jha, Leah Meuter, Guillaume Nicolas, David Taïeb, Karel Pacák
Abstract
The value of in vivo peptide receptor targeting for imaging and treating oncologic patients is well accepted and implemented in clinical practice. A prime example is somatostatin receptor (SSTR)–targeted peptide receptor radionuclide therapy (PRRT), which relies on an image-and-treat approach (
Topics & Concepts
Somatostatin receptorSomatostatinRadionuclide therapyPeptide receptorAntagonistMedicineIn vivoCancer researchReceptorMedical physicsInternal medicineBiologyBiotechnologyNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesRadiopharmaceutical Chemistry and Applications